Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based combination therapy and gene therapy are new strategies to potentially overcome the limitations of TRAIL, however, the lack of efficient and low toxic vectors remains the major obstacle. In this study, we developed a hyaluronic ac...
Main Authors: | Shengpeng Wang, Min Shao, Zhangfeng Zhong, Anqi Wang, Jiliang Cao, Yucong Lu, Yitao Wang, Jinming Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2017.1406558 |
Similar Items
-
Hyaluronic acid-decorated redox-sensitive chitosan micelles for tumor-specific intracellular delivery of gambogic acid
by: Xu W, et al.
Published: (2019-06-01) -
Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
by: Li-Juan Chen, et al.
Published: (2012-05-01) -
Effect of Gambogic Acid–Loaded Porous-Lipid/PLGA Microbubbles in Combination With Ultrasound-Triggered Microbubble Destruction on Human Glioma
by: Feng Wang, et al.
Published: (2021-09-01) -
Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment
by: Zhang Z, et al.
Published: (2017-02-01) -
Gambogic acid improves non-small cell lung cancer progression by inhibition of mTOR signaling pathway
by: Teng Zhao, et al.
Published: (2017-11-01)